The 2025 ISPE Aseptic Conference will take place 17-18 March in Washington, D.C., United States and virtually.
NORTH BETHESDA, Md., Feb. 11, 2025 /PRNewswire-PRWeb/ -- The International Society for Pharmaceutical Engineering (ISPE) has announced planned featured speakers for the 2025 ISPE Aseptic Conference, taking place Monday, 17 March, through Tuesday, 18 March, in Washington D.C., United States and virtually.
"We have brought together an incredible set of presentations covering key technology advancements for the 2025 ISPE Aseptic Conference," said Christa Myers, 2025 ISPE Aseptic Conference International Program Committee Chair and Senior Fellow of Aseptic Sterile Products, Vertical Market Leader with CRB. "Topics include the manufacturing of antibody-drug conjugates (ADCs), Pharma 4.0™-based visual inspections, material transfer improvements, and sterility and release advancements."
The 2025 ISPE Aseptic Conference focuses on trending technologies with practical how-to insights, featuring deep technical case studies, real-life examples of implementations that meet Annex 1 requirements, and new aseptic processing trends. Attendees will learn the latest insights on a range of topics such as advanced filling technologies, contamination control strategies (CCS) including discussions on Annex 1 CCS, and the handling of single-use systems.
"Attendees will benefit from receiving the latest updates on sterile products and aseptic processing, as well as insights on new modalities, such as radiopharmaceuticals, advanced therapy medicinal products (ATMPs) including cell and gene therapies, and more," said Joerg Zimmermann, a member of the 2025 Aseptic Conference International Program Committee and Vice President Vetter Development Service External Affairs with Vetter Pharma Fertigung GmbH & Co KG. "For example, one of our keynote presentations will be titled, 'The New Wave for Radiopharmaceuticals: Navigating the Next Frontier of Precision Medicine and Therapeutic Innovation.' This session is not to be missed."
Featured Tracks Include:
- Advanced Modalities
- ATMPs
- Case Studies
- Filling Operations
- Regulations and Pharma 4.0
- Sterility and Release
Confirmed Speakers Include:
- Matt Edwards, Senior Vice President, Indianapolis Parenteral Manufacturing, Eli Lilly and Company
- Sumit Verma, CEO, Tag1 Inc.
Planned US FDA Speakers:
- Sandra Boyd, Drug National Expert, FDA/ORA
- Talia Faison, Biologist, Product Quality Research-Review, CDER/FDA
- Rick Friedman, Deputy Director, Office of Manufacturing Quality, FDA/CDER
- Robert Sausville, Director, Division of Case Management, FDA/CBER/OMPT/OCBQ
Learn more and register for the 2025 ISPE Aseptic Conference today by visiting https://ISPE.org/aseptic25.
Speaker Qualifications
Speakers selected to present at ISPE events are leading professionals in their fields. However, it may be necessary to make substitutions. Every possible effort will be made to substitute a speaker with comparable qualifications.
Agenda Changes
The agenda is subject to change. Last-minute changes due to functional, private, or organizational needs may be necessary. ISPE accepts no liability for any additional costs caused by a change of the agenda.
About ISPE
The International Society for Pharmaceutical Engineering (ISPE) is a global nonprofit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 22,000+ members of ISPE provide solutions to complex pharmaceutical industry challenges through innovation, member and workforce development, and technical, regulatory, and compliance collaborations in more than 120 countries worldwide. Founded in 1980, ISPE has its worldwide headquarters and training center in North Bethesda, Maryland, USA, and its operations center in Tampa, Florida, USA. For more information, visit ISPE.org.
Media Contact
Katie LeChase, ISPE, +1-360-718-9771, [email protected], https://ISPE.org/
SOURCE ISPE
Share this article